David Mc Erlane is Group President, Biologics of Catalent, Inc.. Currently has a direct ownership of 0 shares of CTLT, which is worth approximately $0. The most recent transaction as insider was on Dec 18, 2024, when has been sold 47,730 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

David McErlane Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2024
SELL
Sale (or disposition) back to the issuer
-
47,730 Reduced 100.0%
0 Common Stock
Dec 18 2024
BUY
Grant, award, or other acquisition
-
11,426 Added 50.0%
11,426 Common Stock
Sep 26 2024
SELL
Open market or private sale
$119,580 $59.97 p/Share
1,994 Reduced 5.21%
36,304 Common Stock
Jul 26 2024
BUY
Grant, award, or other acquisition
-
18,746 Added 32.86%
38,298 Common Stock
DM

David Mc Erlane

Group President, Biologics
Somerset, NJ

Track Institutional and Insider Activities on CTLT

Follow Catalent, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTLT shares.

Notify only if

Insider Trading

Get notified when an Catalent, Inc. insider buys or sells CTLT shares.

Notify only if

News

Receive news related to Catalent, Inc.

Track Activities on CTLT